Zobrazeno 1 - 10
of 264
pro vyhledávání: '"Joo Kyung Park"'
Autor:
Dong Kee Jang, So Jeong Kim, Hwe Hoon Chung, Jae Min Lee, Seung Bae Yoon, Jong-Chan Lee, Dong Woo Shin, Jin-Hyeok Hwang, Min Kyu Jung, Yoon Suk Lee, Hee Seung Lee, Joo Kyung Park, Korean Society of Gastrointestinal Cancer
Publikováno v:
Gut and Liver, Vol 18, Iss 4, Pp 729-736 (2024)
Background/Aims: Palliative chemotherapy (PC) is not standardized for patients with advanced ampulla of Vater adenocarcinoma (AA). This multicenter, retrospective study evaluated first-line PC outcomes in patients with AA. Methods: Patients diagnosed
Externí odkaz:
https://doaj.org/article/3b9e84fcebca4c0dab83d7e00dd7b5c6
Autor:
Joo Kyung Park, Hyoung-oh Jeong, Hyemin Kim, Jin Ho Choi, Eun Mi Lee, Seunghoon Kim, Jinho Jang, David Whee-Young Choi, Se-Hoon Lee, Kyoung Mee Kim, Kee-Taek Jang, Kwang Hyuck Lee, Kyu Taek Lee, Min Woo Lee, Jong Kyun Lee, Semin Lee
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Intratumoral heterogeneity (ITH) and tumor microenvironment (TME) of pancreatic ductal adenocarcinoma (PDAC) play important roles in tumor evolution and patient outcomes. However, the precise characterization of diverse cell popul
Externí odkaz:
https://doaj.org/article/f7e91e3225c14813a26af18da590a5ed
Autor:
In Rae Cho, Sang Hyub Lee, Jin Ho Choi, Joo Kyung Park, Gunn Huh, Woo Hyun Paik, Do Hyun Park
Publikováno v:
BMJ Open, Vol 14, Iss 7 (2024)
Introduction Endoscopic retrograde cholangiopancreatography (ERCP) plays an indispensable role in treating pancreato-biliary diseases but carries a risk of post-ERCP pancreatitis (PEP). Despite advances in the prevention strategies, prevention of PEP
Externí odkaz:
https://doaj.org/article/a29fb1e27f4b420484aa1ed8770a201c
Autor:
Eunae Cho, Seong-Hun Kim, Seong Ji Choi, Min Kyu Jung, Byeong Jun Song, Jin Myung Park, Jingu Kang, Won Suk Park, Joo Kyung Park, Sang Myung Woo, Hyo Jung Kim, Study Group for Biliary Diseases, Korean Pancreatobiliary Association
Publikováno v:
Gut and Liver, Vol 18, Iss 1, Pp 174-183 (2024)
Background/Aims: Based on their anatomy, cholangiocarcinomas (CCAs) are classified into intrahepatic, hilar, and distal CCAs. Although the diagnosis and treatment of each type of CCA are thought to be different, real-world data studies on the current
Externí odkaz:
https://doaj.org/article/19748d21f8f6448dae42cd6a3f899b35
Autor:
Seung Bae Yoon, Sang Myung Woo, Jung Won Chun, Dong Uk Kim, Jaihwan Kim, Joo Kyung Park, Hoonsub So, Moon Jae Chung, In Rae Cho, Jun Heo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundRecently, anti-programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immunotherapy offers promising results for advanced biliary tract cancer (BTC). However, patients show highly heterogeneous responses to treatment, and
Externí odkaz:
https://doaj.org/article/dfa136223c594cb78462013b43e098b6
Autor:
Kangpyo Kim, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Seok Heo, Sang Hyun Shin, Ji Hye Min, Kyunga Kim, In Woong Han
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 45, Iss , Pp 100732- (2024)
Background: To evaluate the efficacy and optimal timing of local treatment in patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX. Method: Between 2015 and 2020, 258 patients with panc
Externí odkaz:
https://doaj.org/article/b61aeb37243a40a3a98e1d0a3242d69d
Autor:
Youngil Koh, Hyemin Kim, So Young Joo, Seulki Song, Young Hoon Choi, Hyung Rae Kim, Byul Moon, Jamin Byun, Junshik Hong, Dong-Yeop Shin, Solip Park, Kwang Hyuck Lee, Kyu Taek Lee, Jong Kyun Lee, Daechan Park, Se-Hoon Lee, Jin-Young Jang, Hyunsook Lee, Jung-Ae Kim, Sung-Soo Yoon, Joo Kyung Park
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-17 (2023)
Abstract Background Lysosomes are closely linked to autophagic activity, which plays a vital role in pancreatic ductal adenocarcinoma (PDAC) biology. The survival of PDAC patients is still poor, and the identification of novel genetic factors for pro
Externí odkaz:
https://doaj.org/article/009bbecbecae404a8ed7c2e23cb50d90
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Several in vivo swine models of benign biliary stenosis (BBS) have been recently reported for preclinical studies of novel endoscopic techniques and devices. The aim of this study was to evaluate the efficacy and feasibility of large animal
Externí odkaz:
https://doaj.org/article/6652f7960b5c4efaa45bb90f4e25a906
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: A regimen of gemcitabine, cisplatin, and nab-paclitaxel (GPA) has shown promising results in patients with advanced biliary tract cancer (aBTC). Objectives: This study aimed to evaluate the benefit of GPA compared to a regimen of gemcitab
Externí odkaz:
https://doaj.org/article/b893d6a07f724bd88b7ecd534a0b554a
Autor:
Ji Eun Kim, Hyemin Kim, Binnari Kim, Hye Gyo Chung, Hwe Hoon Chung, Kyoung Mee Kim, Seong Hyun Kim, Woo Kyoung Jeong, Young Kon Kim, Ji Hye Min, Jin Seok Heo, In Woong Han, Sang Hyun Shin, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Seung Tae Kim, Jung Yong Hong, Se‐Hoon Lee, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Kee‐Taek Jang, Joo Kyung Park
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7748-7761 (2023)
Abstract Pancreaticobiliary tract cancer has a poor prognosis with unmet needs in a new target treatment. Some studies have reported that an enhancement of T‐cell immunity is associated with a good prognosis. The aim of this study is to investigate
Externí odkaz:
https://doaj.org/article/9071de54d0284ff989a250770586c1f5